EMAIL DETAILS
SUBJECT:
Input needed
PRI: NORMAL
FROM:
J
jdeloche@rosemontseneca.com
DATE:
2011-11-04 03:28:12
MSG_ID:
<CABFb5Z2grS7gTmymV7gQMxAQTEx1m0ia1ZdnQggKbWpRmso9VQ@mail.gmail.com>
RECIPIENTS:
TO:
A
Arlene Busch
<abusch@rosemontseneca.com>
D
Devon Archer
<darcher@rosemontcapital.com>
E
Eric Schwerin
<eschwerin@rosemontseneca.com>
H
Hunter Biden
<hbiden@rosemontseneca.com>
N
Neil Callahan
<ncallahan@rosemontseneca.com>
R
Rob Walker
<rwalker@rosemontseneca.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Hi All, Founder's Fund completed its $12mm investment in Counsyl today. I had a call with Counsyl management this evening and they asked if we could be helpful with regulatory channels in NY. Specifically, their lab and test have been approved in 49 states at this point and their lab has been approved by the State of New York, however the test itself is still in in the approval process in NY. NY and CA are two states which require separate lab approval and individual test approval. Counsyl has been told that NY's genetic test approval timing is currently as long as 12 months given current backlog. Specifically, they want us to help them with a roadmap for who we would help them contact at the NY State government level that could help them with this process. One idea discussed, which may or may not be the right one, would be to see if we can get them in front of or on a call with Dr. Nirav Shah, a Governor Cuomo appointee, who is the Commissioner for the NY State Sept of Health. The message would be that Counyl's test is the highest standard of care for expecting parents and it is currently approved in 49 states but not New York. I'd appreciate it if we could have a call to discuss. They are looking for high level feedback, and potentially a call with us on this subject, by Monday. Thanks, John -- John DeLoche *Managing Director* Rosemont Seneca Technology Partners One Market, Spear Tower, 36th Floor San Francisco, CA 94105 office: 415 293 8147 mobile: 415 793 7070 This email communication is privileged and confidential and is intended only for the individuals or entities named above. Any unauthorized dissemination of any of the contents of this email is strictly prohibited. If you are not the intended recipient, please do not read, copy, use or disclose to others the contents of this communication. Please notify the sender that you have received this e-mail in error and then delete the e-mail
METADATA:
THREAD:
INDEX:
Adhhn0ArHSMTz6M0RWu5IoWLPopeRA==